Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting-Reference-Cited by-同舟云学术

Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting

Published:2009-07-19 Issue:3 Volume:64 Page:616-624
ISSN:1460-2091
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Zazzi Maurizio,Prosperi Mattia,Vicenti Ilaria,Di Giambenedetto Simona,Callegaro Annapaola,Bruzzone Bianca,Baldanti Fausto,Gonnelli Angela,Boeri Enzo,Paolini Elisabetta,Rusconi Stefano,Giacometti Andrea,Maggiolo Franco,Menzo Stefano,De Luca Andrea

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/64/3/616/13759255/dkp252.pdf

Reference17 articles.

1. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel;Hammer;JAMA,2008

2. Web resources for HIV type 1 genotypic-resistance test interpretation;Liu;Clin Infect Dis,2006

3. Interpreting resistance data for HIV-1 therapy management—know the limitations;Van Laethem;AIDS Rev,2006

4. Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance;De Luca;J Infect Dis,2003

5. Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patients;King;Antimicrob Agents Chemother,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study;Journal of Medical Virology;2022-04-09

2. Pretreatment HIV drug resistance and treatment failure in non-Italian HIV-1-infected patients enrolled in ARCA;Antiviral Therapy;2020

3. Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort;HIV Medicine;2018-11-21

4. Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA);Journal of Clinical Virology;2018-08

5. Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study;Open Forum Infectious Diseases;2018-05-15